Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis; antibodies for the prevention or treatment of autoimmune diseases; small molecules, gene therapies and peptides for the prevention or treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis and organ damage due to sepsis

'antibodi':26,50 'arthriti':12,36,76 'asthma':8,32,72 'autoimmun':57 'cancer':7,31,71 'coliti':19,43,83 'copd':9,33,73 'damag':22,46,86 'diseas':18,42,58,82 'due':23,47,87 'fibrosi':16,40,80 'gene':61 'idiopath':14,38,78 'lung':17,41,81 'lupus':10,34,74 'molecul':60 'organ':21,45,85 'peptid':64 'pharmaceut':1 'prepar':2 'prevent':53,67 'pulmonari':15,39,79 'rheumatoid':11,35,75 'sepsi':25,49,89 'small':59 'therapi':62 'treatment':5,29,55,69 'vascul':13,37,77

CITRYLL

Owners

Goods & Services